• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022July

Month: July 2022

Stock News

Q3 Outlook For Stocks: Bullish Into Peak Inflation Narrative (NYSEARCA:SPY)

July 1, 2022 admin 0

utah778/iStock via Getty Images Good riddance to Q2. It was a terrible quarter for stocks with the S&P 500 (NYSEARCA:SPY) crashing by 16% representing the bulk of its 21% year-to-date decline. The big story was […]

Stock News

AGNC Investment: Very Risky 12.6% Yield (NASDAQ:AGNC)

July 1, 2022 admin 0

skynesher/iStock via Getty Images AGNC Investment Corp. (NASDAQ:AGNC) has a history of cutting dividends, and a new round of book value losses and declining income could force the mortgage trust to cut its dividend yet […]

Stock News

Micron Earnings: It’s All Over! Or Is It? (NASDAQ:MU)

July 1, 2022 admin 0

knowlesgallery/iStock Editorial via Getty Images Leading up to Micron’s (NASDAQ:MU) FQ3 report, the stock had plummeted from $66 to $55. It seemed the market was getting ahead of some bad news. Then the last two […]

Posts navigation

« 1 … 2,299 2,300 2,301 … 2,356 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Parex Resources: Best In Class Debt Free Bet On Colombian Oil (OTCPK:PARXF)
    January 25, 2023 0
  • Is Medical Properties Trust A Good Dividend Stock? (NYSE:MPW)
    June 27, 2022 0
  • Wall Street to tumble as second Fed rate cut fans fears By Reuters
    March 16, 2020 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.